228 related articles for article (PubMed ID: 15950742)
41. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells.
Resende DM; Caetano BC; Dutra MS; Penido ML; Abrantes CF; Verly RM; Resende JM; Piló-Veloso D; Rezende SA; Bruna-Romero O; Fernandes AP; Gazzinelli RT
Vaccine; 2008 Aug; 26(35):4585-93. PubMed ID: 18588933
[TBL] [Abstract][Full Text] [Related]
42. Potential of KM+ lectin in immunization against Leishmania amazonensis infection.
Teixeira CR; Cavassani KA; Gomes RB; Teixeira MJ; Roque-Barreira MC; Cavada BS; da Silva JS; Barral A; Barral-Netto M
Vaccine; 2006 Apr; 24(15):3001-8. PubMed ID: 16455170
[TBL] [Abstract][Full Text] [Related]
43. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
Tonui WK; Titus RG
Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
[TBL] [Abstract][Full Text] [Related]
44. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
Khoshgoo N; Zahedifard F; Azizi H; Taslimi Y; Alonso MJ; Rafati S
Vaccine; 2008 Oct; 26(46):5822-9. PubMed ID: 18804512
[TBL] [Abstract][Full Text] [Related]
45. Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis.
Alves CR; Benévolo-De-Andrade TC; Alves JL; Pirmez C
Parasite Immunol; 2004 Mar; 26(3):127-35. PubMed ID: 15279623
[TBL] [Abstract][Full Text] [Related]
46. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages.
Shimizu Y; Takagi H; Nakayama T; Yamakami K; Tadakuma T; Yokoyama N; Kojima N
Parasite Immunol; 2007 May; 29(5):229-39. PubMed ID: 17430546
[TBL] [Abstract][Full Text] [Related]
47. [Efficacy of the vaccination of C57BL/6 mice against infection with different species of Leishmania].
Monjour L; Ogunkolade W; Pointet P; Vouldoukis I
C R Acad Sci III; 1985; 301(18):803-6. PubMed ID: 3936605
[TBL] [Abstract][Full Text] [Related]
48. Co-administration of chitin micro-particle and Leishmania antigen proposed a new immune adjuvant against experimental leishmaniasis.
Azizi M; Yousefi R; Yeganeh F; Mami S; Haji Molla Hoseini M
Parasite Immunol; 2019 Dec; 41(12):e12676. PubMed ID: 31593609
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-18 enhances a Th2 biased response and susceptibility to Leishmania mexicana in BALB/c mice.
Bryson KJ; Wei XQ; Alexander J
Microbes Infect; 2008 Jun; 10(7):834-9. PubMed ID: 18538609
[TBL] [Abstract][Full Text] [Related]
50. [Monoclonal antibodies against defined Leishmania antigens protect mice against infection by different species of Leishmania].
Monjour L; Berneman A; Vouldoukis I; Domurado M; Guillemin MC; Chopin C; Alfred C; Roseto A
C R Acad Sci III; 1985; 300(9):395-8. PubMed ID: 3922585
[TBL] [Abstract][Full Text] [Related]
51. Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.
Aebischer T; Wolfram M; Patzer SI; Ilg T; Wiese M; Overath P
Infect Immun; 2000 Mar; 68(3):1328-36. PubMed ID: 10678945
[TBL] [Abstract][Full Text] [Related]
52. Genetic control of the immune response in mice to Leishmania mexicana surface protease.
López JA; Reins HA; Etges RJ; Button LL; McMaster WR; Overath P; Klein J
J Immunol; 1991 Feb; 146(4):1328-34. PubMed ID: 1991971
[TBL] [Abstract][Full Text] [Related]
53. Protein-energy malnutrition decreases immune response to Leishmania chagasi vaccine in BALB/c mice.
Malafaia G; Serafim TD; Silva ME; Pedrosa ML; Rezende SA
Parasite Immunol; 2009 Jan; 31(1):41-9. PubMed ID: 19121082
[TBL] [Abstract][Full Text] [Related]
54. Sex-determined resistance against Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but not male DBA/2 mice.
Satoskar A; Al-Quassi HH; Alexander J
Immunol Cell Biol; 1998 Apr; 76(2):159-66. PubMed ID: 9619486
[TBL] [Abstract][Full Text] [Related]
55. Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells.
Carrión J; Folgueira C; Alonso C
Vaccine; 2008 May; 26(20):2537-44. PubMed ID: 18400342
[TBL] [Abstract][Full Text] [Related]
56. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
[TBL] [Abstract][Full Text] [Related]
57. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
[TBL] [Abstract][Full Text] [Related]
58. CD4+ T cells play a dominant role in protection against New World leishmaniasis induced by vaccination with the P-4 amastigote antigen.
Kar S; Metz C; McMahon-Pratt D
Infect Immun; 2005 Jun; 73(6):3823-7. PubMed ID: 15908422
[TBL] [Abstract][Full Text] [Related]
59. Subspecies- and species-specific antigens of Leishmania mexicana characterized by monoclonal antibodies.
Pratt DM; Bennett E; Grimaldi G; Jaffe CL
J Immunol; 1985 Mar; 134(3):1935-40. PubMed ID: 2578524
[TBL] [Abstract][Full Text] [Related]
60. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
